Genmab A/S (LON:0MGB)
2,180.48
-33.22 (-1.50%)
At close: Jan 16, 2026
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
1.07M GBP
Profits / Employee
439.33K GBP
Market Cap
14.61B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,682 | 478 | 21.69% |
| Dec 31, 2023 | 2,204 | 544 | 32.77% |
| Dec 31, 2022 | 1,660 | 448 | 36.96% |
| Dec 31, 2021 | 1,212 | 431 | 55.19% |
| Dec 31, 2020 | 781 | 233 | 42.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| BAE Systems | 107,400 |
| BP p.l.c. | 100,500 |
| Shell | 96,000 |
| AstraZeneca | 94,300 |
| Barclays | 93,000 |
| GSK plc | 68,629 |
Genmab News
- 3 days ago - AbbVie And Genmab: Phase 3 EPCORE DLBCL-1 Trial Shows PFS Gains But No Significant OS Benefit - Nasdaq
- 3 days ago - Genmab (GMAB) Phase 3 Trial Results: Impact and Future Outlook - GuruFocus
- 3 days ago - Genmab's (GMAB) Epcoritamab Shows Promise in DLBCL Trial - GuruFocus
- 3 days ago - Genmab down after trial data for AbbVie-partnered Epkinly in B-cell lymphoma - Seeking Alpha
- 3 days ago - AbbVie (ABBV) and Genmab Advance Epcoritamab Trials for Lymphoma - GuruFocus
- 3 days ago - Genmab and AbbVie's blood cancer drug fails to improve survival in late-stage study - Reuters
- 3 days ago - Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Business Wire
- 5 days ago - Genmab A/S (GMAB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha